Avestar Capital »

Vaneck Vectors Pharmaceutical etf shares owned by Avestar Capital

Quarter-by-quarter ownership of Vaneck Vectors Pharmaceutical etf (PPH) shares owned by Avestar Capital from 13F filings

Historical chart of Avestar Capital investment in Vaneck Vectors Pharmaceutical etf

Tip: Access up to 7 years of quarterly data

All positions including Vaneck Vectors Pharmaceutical etf held by Avestar Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaneck Vectors Pharmaceutical etf by Avestar Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $4.3M 53k 81.37

More positions owned by Avestar Capital

Alphabet Cap Stk Cl C (GOOG)
Apple (AAPL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Actively Managed Etf Ultra Shrt Dur (GSY)
J P Morgan Exchange Traded F Ultra Shrt Inc (JPST)
Pgim Etf Tr Pgim Ultra Sh Bd (PULS)
First Tr Exchange-traded First Tr Enh New (FTSM)
Ssga Active Etf Tr Ult Sht Trm Bd (ULST)
Wisdomtree Tr Floatng Rat Trea (USFR)
Meta Platforms Cl A (META)
Ishares Tr Blackrock Ultra (ICSH)
Microsoft Corporation Put Option (MSFT)
Goldman Sachs Etf Tr Aces Ultra Shr (GSST)
Amazon (AMZN)
Invesco Exchange Traded Fd T S&p 500 Top 50 (XLG)

View all positions for Avestar Capital

Top funds holding Vaneck Vectors Pharmaceutical etf

Goldman Sachs Group
Bank of America Corporation
Healthcare Of Ontario Pension Plan Trust Fund
Avalon Trust
Jpmorgan Chase & Co
Miller Investment Management
Prime Capital Investment Advisors
Bnp Paribas Arbitrage, Snc
Independent Advisor Alliance
Phoenix Holdings
Citadel Advisors
Avestar Capital
Gladstone Institutional Advisory
Hrt Financial
Twelve Points Wealth Management

View all funds holding Vaneck Vectors Pharmaceutical etf